Since 2011, when Samsung BioLogics started its operations, it has moved and grown to quit rapidly. In nine years, this South Korean contract development and manufacturing organization has established over 180,000L dream plants. These facilities are a bit advanced and more extensive, making Samsung BioLogics one of the global biggest contract manufacturers.

Dr. Tae Han Kim has been on the helm of this company since its inception, and he acts as Samsung Biologics CEO and founder. He is committed to transforming Samsung Biologics into a world-class biomedicine organization that is trusted by its clients and partners.

Since the diversification and expansion of Samsung group into the pharmaceutical industry, Dr. Han has served as the founding Samsung Biologics CEO. Through his vast knowledge and experience in various sectors, Dr. Kim brings to the table a wealth of business expertise and innovation necessary to steer Samsung biologics to the global scene.

Dr. Tae Han is a firm believer in a customer-centric business model; that’s why at Samsung biologics, this model is actively used and supported in the development of the novel drug as well as in coming up with superior quality, fast turnaround manufacturing partnerships. All the facilities at Samsung BioLogics come equipped with the latest technology equipment, and they are global CGMP compliant. With such facilities and infrastructure in place, Samsung biologics under the stewardship of Dr. Han has become a market leader in the manufacture and distribution of biopharmaceuticals globally. All this is in line with their commitment to making a difference in global healthcare.

Dr. Kim starts his typical day with some set free mind meditation exercise, which he says brings his mind back to the present. He takes his past as a learning experience and always not allow regrets to take up his remaining energy. He focuses on living his best life at the moment.